Statin prescribing in Northern Ireland and England pre and post introduction of the quality and outcomes framework

Ibrahim Alabbadi, Grainne Crealey, Lyndsay Turner, Therese Rafferty, Lynn Keenan, P Murray, James McElnay

Research output: Contribution to journalArticlepeer-review

7 Citations (Scopus)

Abstract

Objective The objective of this research was to examine differences in patterns of statin prescribing between Northern Ireland and England both before and after the introduction of the Quality and Outcomes Framework (QOF). Setting: Primary care practices in Northern Ireland and England. Method Northern Ireland practices were matched with practices in England, statin prescribing data and QOF achievement scores (for the first year post-QOF) were obtained. Crude prescribing data from matched practices were manipulated to provide a data set of Defined Daily Doses (DDDs)/1,000 patients and cost/DDD/1,000 patients for each statin drug entity covering 1 year before and after the introduction of QOF. QOF achievements were converted into percentage scores for matched practices. Main outcome measure Cost per defined daily dose (DDD) per 1,000 patients. Results Significantly less statins (DDD/1,000 patients) were dispensed in Northern Ireland compared with the matched region in England both before and after the introduction of QOF (P
Original languageEnglish
Pages (from-to)43-51
Number of pages9
JournalPharmacy World & Science
Volume32
Issue number1
DOIs
Publication statusPublished - Feb 2010

ASJC Scopus subject areas

  • Pharmacology (medical)
  • Pharmaceutical Science
  • Pharmacology
  • Toxicology
  • Pharmacy

Fingerprint

Dive into the research topics of 'Statin prescribing in Northern Ireland and England pre and post introduction of the quality and outcomes framework'. Together they form a unique fingerprint.

Cite this